refractory immune thrombocytopenia

DBCOND0021524Allergic DiseasesAnatomical Structures and Fluids

refractory immune thrombocytopenia is the indication for 2 drugs in DrugBank. It is covered by 2 curated, structured indications.

Classified under
Indicated drugs

What you can answer from here — as of October 24, 2026

2Indicated drugsWith each drug's targets and mechanism
Listed above
2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
1Clinical trialPhase, status and sponsor resolved per trial
Sign in

Which approved drugs for refractory immune thrombocytopenia share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In